Literature DB >> 195054

Antiviral activity of some beta-diketones. 1. Aryl alkyl diketones. In vitro activity against both RNA and DNA viruses.

G D Diana, U J Salvador, E S Zalay, R E Johnson, J C Collins, D Johnson, W B Hinshaw, R R Lorenz, W H Thielking, F Pancic.   

Abstract

The discovery that 4-[3-ethyl-6-[(3,4-methylenedioxy)phenyl]-3-hexenyl]-3,5-heptanedione (40) exhibited an in vitro inhibitory effect against equine rhinovirus led to a structure--activity study to establish the criteria for optimum activity. Modification of the bridge included removal of the ethyl group and reduction of the double bond. The heptanedione was replaced with hexanedione and pentanedione with a minimal effect. The effect of replacing the heptanedione with beta-keto esters and monoketones was also investigated. Maintaining the hexamethylene bridge and heptanedione, the methylenedioxy group was replaced with various substitutents. In general, most substituents did not adversely affect activity particularly against equine rhinovirus although there was some variation in activity against herpesvirus. Strongly hydrophilic groups significantly reduced activity. Finally, the effect of varying the length of the alkyl bridge was examined in the 4-hydroxyphenyl series, where peak activity was attained with n = 8.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 195054     DOI: 10.1021/jm00216a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.

Authors:  Anna Egorova; Sean Ekins; Michaela Schmidtke; Vadim Makarov
Journal:  Eur J Med Chem       Date:  2019-06-11       Impact factor: 6.514

2.  Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.

Authors:  M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  Antirhinovirus activity of purine nucleoside analogs.

Authors:  E De Clercq; R Bernaerts; D E Bergstrom; M J Robins; J A Montgomery; A Holy
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

4.  Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection.

Authors:  F Pancic; B A Steinberg; G D Diana; P M Carabateas; W G Gorman; P E Came
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

5.  Antiviral activity of arildone on deoxyribonucleic acid and ribonucleic acid viruses.

Authors:  K S Kim; V J Sapienza; R I Carp
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

6.  Disposition of arildone, an antiviral agent, after various routes of administration.

Authors:  D P Benziger; J Edelson
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

7.  Oral efficacy of WIN 51711 in mice infected with human poliovirus.

Authors:  M A McKinlay; B A Steinberg
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

8.  Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species.

Authors:  Kristina Lanko; Liang Sun; Mathy Froeyen; Pieter Leyssen; Leen Delang; Carmen Mirabelli; Johan Neyts
Journal:  Antiviral Res       Date:  2021-09-10       Impact factor: 5.970

9.  Chapter 4 Picornavirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29

Review 10.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.